Anorexigenic and orexigenic hormone modulation of mammalian target of rapamycin complex 1 activity and the regulation of hypothalamic agouti-related protein mRNA expression

NeuroSignals

Volumn 21, Issue 1-2, 2013, Pages 28-41

  Watterson, Kenneth R ^a   Bestow, Dawn ^a   Gallagher, Jennifer ^a   Hamilton, D Lee ^a   Ashford, Fiona B ^a   Meakin, Paul J ^a   Ashford, Michael L J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

AgRP; AMP activated protein kinase; Ghrelin; Hypothalamus; Insulin; Leptin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; AGOUTI RELATED PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE 2; GHRELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME REPRESSION; EXTRACELLULAR CALCIUM; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HORMONE INHIBITION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84876136263     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000334144     Document Type: Article

References (46)

1. Dixon JB: The effect of obesity on health outcomes. Mol Cell Endocrinol 2010; 316: 104-108
2. Thaler JP, Choi SJ, Schwartz MW, Wisse BE: Hypothalamic inflammation and energy homeostasis: Resolving the paradox. Front Neuroendocrin 2010; 31: 79-84
3. Niswender KD, Baskin DG, Schwartz MW: Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol Metab 2004; 15: 362-369
4. Niswender KD, Schwartz MW: Insulin and leptin revisited: Adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 2003; 24: 1-10
5. Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinyo S, Colmers WF, Cone RD, Horvath TL: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661
6. Cone RD: Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005; 8: 571-578
7. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I: Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50: 2438-2443
8. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ: Hypothalamic mTOR signaling regulates food intake. Science 2006; 312: 927-930
9. Villanueva EC, Münzberg H, Cota D, Leshan RL, Kopp K, Ishida-Takahashi R, Jones JC, Fingar DC, Seeley RJ, Myers Jr MG: Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. Endocrinology 2009; 150: 4541-4551
10. Cota D, Matter EK, Woods SC Seeley RJ: The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci 2008; 28: 7202-7208
11. Blouet C, Ono H, Schwartz GJ: Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab 2008; 8: 459-467
12. Reed AS, Unger EK, Olofsson LE, Piper ML, Myers MG Jr, Xu AW: Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and longterm energy homeostasis. Diabetes 2010; 59: 894-906
13. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G: Absence of S6K1 protects against age-and dietinduced obesity while enhancing insulin sensitivity. Nature 2004; 431: 200-205
14. Miller AM, Brestoff JR, Phelps CB, Berk EZ, Reynolds TH 4th: Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice. Am J Physiol Regul Integr Comp Physiol 2008; 295:R1431-R1438
15. Korsheninnikova E, van der Zon GC, Voshol PJ, Janssen GM, Havekes LM, Grefhorst A, Kuipers F, Reijngoud DJ, Romijn JA, Ouwens DM, Maassen JA: Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 2006; 49: 3049-3057
16. Sun Y, Wang P, Zheng H, Smith RG: Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679-4684
17. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK: Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005; 115: 3564-3572
18. Hewson AK, Dickson SL: Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinology 2000; 12: 1047-1049
19. Wang L, Saint-Pierre HH, Taché Y: Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 2002; 325: 47-51
20. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ: AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004; 279: 12005-12008
21. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits M: Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 2005; 280: 25196-25201
22. Minokoshi Y, Alquier T, Furukawa N, Kim Y-B, Lee A, Xua B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn, BB: AMP-kinase regulated food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-574
23. Shaw RJ: LKB1 and AMP-activated protein kinase control of mTOR signaling and growth. Acta Physiol Scand 2009; 196: 65-80
24. Mirshamsi S, Laidlaw HA, Ning K, Anderson E, Burgess LA, Gray A, Sutherland C, Ashford ML: Stimulation of PI3K by leptin and insulin leads to actin reorganization and K ATP activation in arcuate nucleus neurones. BMC Neurosci 2004; 5: 54
25. Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, Towler MC, Brown LJ, Ogunbayo OA, Evans AM, Hardie DG: Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 2010; 11: 554-565
26. Huang J, Manning BD: A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 2009; 37: 217-222
27. Toral-Barza L, Zhang WG, Lamison C, Larocque J, Gibbons J, Yu K: Characterization of the cloned fill-length and a truncated human target of rapamycin: Activity, specificity, and enzyme inhibition as studied by a high capacity assay. Biochem Biophys Res Commun 2005; 332: 304-310
28. Bain J, Plater L, Elliot M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P: The selectivity of protein kinase inhibitors: A further update. Biochem J 2007; 408: 297-315
29. Dann SG, Thomas G: The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett 2006; 580: 2821-2829
30. Logie L, Ruiz-Alcaraz AJ, Keane M, Woods YL, Bain J, Marquez R, Alessi DR, Sutherland C: Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells. Diabetes 2007; 56: 2218-2227
31. Lage R, Vásquez MJ, Varela L, Saha AK, Vidal-Puig A, Nogueiras R, Diéguez C, López, M: Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 2010; 24: 2670-2679
32. Towler MC, Hardie DG: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007; 100: 328-341
33. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE, Means AR: Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab 2008; 7: 377-388
34. Schellekens H, Dinan TG, Cryan JF: Lean mean fat reducing 'ghrelin' machine: hypothalamic ghrelin and ghrelin receptors and therapeutic targets in obesity. Neuropharmacology 2009; 58: 2-16
35. Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R: STO-609, a specific inhibitor of the Ca 2+/calmodulin-dependent protein kinase kinase. J Biol Chem 2002; 277: 15813-15818
36. López M, Lage R, Saha AK, Pérez-Tilve D, Vázquez MJ, Varela, L, Sangiao-Alverellos S, Tovar S, Raghay K, Rodríguez-Cuenca S, Deoliveira RM, Castañeda T, Datta R, Dong JZ, Culler M, Sleeman MW, Álvarez CV, Gallego R, Lelliot CJ, Carling D, Tschöp MH, Diéguez C, Vidal-Puig A: Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008; 7: 389-399
37. Kola B, Korbonits M: Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. J Endocrinol 2009; 202: 191-198
38. Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, Carmignac D, Martinez J, Guerineau NC, Robinson IC, Mollard P, Méry PF: Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS One 2010; 11:e9159
39. Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T: Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003; 52: 948-956
40. Kohno D, Sone H, Minokoshi Y, Yada T: Ghrelin raises [Ca 2+] I via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem Biophys Res Commun 2008; 366: 388-392
41. Erriquez J, Bernascone S, Ciarletta M, Filigheddu N, Graziani A, Distasi C: Calcium signals activated by ghrelin and D-Lys 3-GHRP-6 ghrelin antagonist in developing dorsal root ganglion glial cells. Cell Calcium 2009; 46: 197-208
42. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro KLK, Ladenheim EE, Ronnett GV, Tu U, Birnbaum MJ, Lopaschuk GD, Moran TH: Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci USA 2007; 104: 17358-17363
43. Ropelle ER, Pauli JR, Fernandes MFA, Rocco SA, Marin RM, Morari J, Souza KK, Dias MM, Gomes-Marcondes MC, Gontijo JAR, Franchini KG, Vellosa LA, Saad MJA, Carvalheira JBC: A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 2008; 57: 594-605
44. Ropelle ER, Fernandes MF, Flores MB, Ueno M, Rocco S, Marin R, Cintra DE, Velloso LA, Franchini KG, Saad MJ, Carvalheira JB: Central exercise action increases the AMPK and mTOR response to leptin. PLoS One 2008; 3:e3856
45. Andrews ZB, Liu Z-W, Wallingford N, Erion DM, Borok E, Friedman JM, Tschöp MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao X-B, Horvath TL, Diano S: UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008; 454: 846-851
46. Cota D, Proulx K, Seeley RJ: The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 2007; 132: 2158-2168.